Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Javelin sues Hospira over stalled merger
Marketwatch
Thursday, June 3, 2010 - 10:03am
tags:
Javelin, M&A, Hospira, lawsuits
Merck Launches Global Trial Network For Cancer-Drug Creation
WSJ Online
Thursday, June 3, 2010 - 9:55am
tags:
Merck, innovation, R&D, cancer
Sleepwalking: Cephalon Takes A Hit On Nuvigil
Pharmalot
Thursday, June 3, 2010 - 9:52am
tags:
NUVIGIL, Cephalon
Glaxo’s Avandia Helps Prevent Diabetes in Low-Dose Combination
Bloomberg
Thursday, June 3, 2010 - 9:50am
tags:
GSK, Avandia, diabetes, metformin
Pharma Job Cuts Exceed 34,000 This Year
Pharmalot
Thursday, June 3, 2010 - 9:49am
tags:
layoffs
Another View: Can Biotech Survive Icahn?
NY Times, NY
Thursday, June 3, 2010 - 9:48am
tags:
biotech, Carl Icahn, Genzyme
Elan CEO Kelly Martin to Step Down in 2012
WSJ Online
Thursday, June 3, 2010 - 9:44am
tags:
Elan, Kelly Martin, Pharma CEOs
Two Biotechs With Promising Charts
TheStreet.com
Thursday, June 3, 2010 - 9:43am
tags:
Ariad Pharmaceuticals, Achillion
Novartis's Afinitor meets Phase III trial endpoint
Marketwatch
Thursday, June 3, 2010 - 9:41am
tags:
Novartis, Afinitor, clinical trials, pancreatic cancer
FDA orders new warning labels on GlaxoSmithKline asthma drugs Serevent, Advair
Bizjournals.com
Thursday, June 3, 2010 - 9:23am
tags:
warnings, Serevent, GSK, FDA, asthma, Advair
Life Technologies Spending $100 Million In Synthetic Biology
Forbes
Wednesday, June 2, 2010 - 6:05pm
tags:
Life Technologies, M&A, Synthetic Genomics, GEneart, synthetic biology
Teva gets FDA approval for generic acne treatment
Yahoo/AP
Wednesday, June 2, 2010 - 6:02pm
tags:
Teva Pharmaceuticals, generics, FDA, acne, Galderma, Differin
Four Scenarios For Bristol-Myers
Forbes
Wednesday, June 2, 2010 - 6:00pm
tags:
Bristol-Myers Squibb, ipilimumab, melanoma
Biotech Exec Charged By SEC For Lying About Data
Pharmalot
Wednesday, June 2, 2010 - 5:19pm
tags:
SEC, Sequenom
Vaccination Rates For Merck’s Gardasil Are Low
Pharmalot
Wednesday, June 2, 2010 - 5:17pm
tags:
Merck, vaccines, HPV, Gardasil
Biogen Idec Sues Other MS Drug Makers
WSJ Online
Wednesday, June 2, 2010 - 5:16pm
tags:
MS, multiple sclerosis, Biogen Idec, Pfizer, Bayer, Novartis, patents, beta-interferon
Bristol's Mysterious Melanoma Medicine
Forbes
Wednesday, June 2, 2010 - 5:14pm
tags:
Bristol-Myers Squibb, melanoma, ipilimumab
Javelin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Wednesday, June 2, 2010 - 5:09pm
tags:
Javelin
Teva CFO: 2010 rev below $16 bln forecast -report
Reuters
Wednesday, June 2, 2010 - 9:48am
tags:
Teva Pharmaceuticals, revenue forecast
SEC Declines To Probe Dendreon Conflict Charges
Pharmalot
Wednesday, June 2, 2010 - 9:31am
tags:
Dendreon, SEC, Provenge

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.